Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/9/2019
SIETES contiene 92806 citas

 1 a 20 de 215 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Branch-Elliman W, O'Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surgery 2019:24 de abril. [Ref.ID 103091]
2.Enlace a cita original Cita con resumen
Thybo KH, Hägi-Pedersen D, Dahl JB, Wetterslev J, Nersesjan M, Jakobsen JC, Pedersen NA, Overgaard S, Schroder HM, Schmidt H, Bjorck JG, Skovmand K, Frederiksen R, Buus-Nielsen M, Vos Sorensen C, Kruuse LS, Lindholm P, Mathiesen O. Effect of combination of paracetamol (acetaminophen) and ibuprofen vs either alone on patient-controlled morphine consumption in the first 24 hours after total hip arthroplasty. The PANSAID randomized clinical trial. JAMA 2019;321:12 de febrero. [Ref.ID 103023]
4. Cita con resumen
Nielen JTH, Dagnelie PC, Emans PJ, Veldhorst-Janssen N, Lalmohamed A, Van Staa T-P, Boonen AERCH, van den Bemt BJF, de Vries F. Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements. Pharmacoepidemiol Drug Saf 2016;25:1245-52. [Ref.ID 100896]
5.Enlace a cita original
Nielen JTH, de Vries F, Dagnelie PC, van den Bemt BJF, Emans PJ, Lalmohamed A, de Boer A, Boonen A. Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case–control study. Br J Clin Pharmacol 2016;81:370-8. [Ref.ID 100098]
6. Cita con resumen
Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, Fleisher L, Beaupre L, Macaulay W, Rhoads GG, Paris B, Zagorin A, Wanders DW, Zakriya KJ, Magaziner J. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015;385:1183-9. [Ref.ID 98991]
7. Cita con resumen
Anónimo. Stryker announces $1B settlement in hip implant class-action suit. DIA Daily 2014:4 de noviembre. [Ref.ID 98275]
8.Tiene citas relacionadas Cita con resumen
Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014;349:g4829. [Ref.ID 98189]
9.Tiene citas relacionadas Cita con resumen
Ker K, Roberts I. Tranexamic acid for surgical bleeding. BMJ 2014;349:g4934. [Ref.ID 98188]
10.Tiene citas relacionadas Cita con resumen
Michaëlsson K. Surgeon volume and complications after total hip arthroplasty. BMJ 2014;348:g3433. [Ref.ID 98024]
11.Tiene citas relacionadas Cita con resumen
Mäkelä KT, Matilainen M, Pulkkinen P, Fenstad AM, Havelin L, Engesaeter L, Furnes O, Pederson AB, Overgaard S, Kärrholm J, Malchau H, Garellick G, Ranstam J, Eskelinen A. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ 2014;348:14. [Ref.ID 97252]
12.Tiene citas relacionadas
Hamilton DF, Howie CR. Selecting the right hip replacement. BMJ 2014;348:g46. [Ref.ID 97250]
13. Cita con resumen
Kynaston-Pearson F, Ashmore AM, Malak TT, Rombach I, Taylor A, Beard D, Arden NK, Price A, Prieto-Alhambra D, Judge A, Carr AJ, Glyn-Jones S. Primary hip replacement prostheses and their evidence base: systematic review of literature. BMJ 2014;347:f6956. [Ref.ID 97210]
14. Cita con resumen
Wise J. Death rate from hip replacement almost halved in eight years. BMJ 2013;347:5. [Ref.ID 96344]
15.Tiene citas relacionadas Cita con resumen
Hunt LP, Ben-Shlomo Y, Clark EM, Dieppe P, Judge A, MacGregor AJ, Tobias JH, Vernon K, Blom AW, on behalf of the National Joint Registry for England Wales and Northern Ireland. 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 2013;382:1097-104. [Ref.ID 96311]
16.Tiene citas relacionadas Cita con resumen
Issa K, Mont MA. Total hip replacement: mortality and risks. Lancet 2013;382:1074-6. [Ref.ID 96310]
17. Cita con resumen
Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T, Carrier M, Vendittoli P-A. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 2013;158:800-6. [Ref.ID 95589]
18. Cita con resumen
Pennington M, Grieve R, Sekhon JS, Gregg P, Black N, van der Meulen JH. Cemented, cementless, and hybrid protheses for total hip replacement: cost effectiveness analysis. BMJ 2013;346:12. [Ref.ID 95410]
19.Enlace a cita original Cita con resumen
Anónimo. FDA safety communication: metal-on-metal hip implants. U.S. Food and Drug Administration 2013:17 de enero. [Ref.ID 94630]
20. Cita con resumen
Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Voer A, Leufkens HGM, van Staa TP, de Vries F. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement. A nationwide cohort study. Arch Intern Med 2012;172:1229-35. [Ref.ID 94317]
Seleccionar todas
 1 a 20 de 215 siguiente >>